CompaniesKanglin Biotechnology

Kanglin Biotechnology

active
Hangzhou, China
Founded 2015
Website
About

AAV Gene Therapy, Stem Cell Platform

Areas of Focus

Categories

Virus TechnologyGene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapyChina
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

3

By Phase

NA: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
NCT06219239
Hover over trial bars to see details

Recent Trials

NCT06219239Collaborator
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
NARecruiting
3 participants
Started: Jan 4, 2024 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Hangzhou, China
Map

Loading map...